- Home
- ICCH vs LNSR Comparison
ICCH vs LNSR Comparison
Compare ICCH & LNSR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ICCH
- LNSR
- Stock Information
- Founded
- ICCH 1950
- LNSR 2004
- Country
- ICCH United States
- LNSR United States
- Employees
- ICCH N/A
- LNSR N/A
- Industry
- ICCH Property-Casualty Insurers
- LNSR Medical Electronics
- Sector
- ICCH Finance
- LNSR Health Care
- Exchange
- ICCH Nasdaq
- LNSR Nasdaq
- Market Cap
- ICCH 68.8M
- LNSR 63.4M
- IPO Year
- ICCH 2017
- LNSR N/A
- Fundamental
- Price
- ICCH $23.29
- LNSR $8.25
- Analyst Decision
- ICCH
- LNSR
- Analyst Count
- ICCH 0
- LNSR 0
- Target Price
- ICCH N/A
- LNSR N/A
- AVG Volume (30 Days)
- ICCH 5.7K
- LNSR 52.9K
- Earning Date
- ICCH 03-03-2025
- LNSR 03-03-2025
- Dividend Yield
- ICCH N/A
- LNSR N/A
- EPS Growth
- ICCH 42.86
- LNSR N/A
- EPS
- ICCH 2.16
- LNSR N/A
- Revenue
- ICCH $92,541,259.00
- LNSR $48,868,000.00
- Revenue This Year
- ICCH N/A
- LNSR $25.07
- Revenue Next Year
- ICCH N/A
- LNSR $24.95
- P/E Ratio
- ICCH $10.77
- LNSR N/A
- Revenue Growth
- ICCH 14.09
- LNSR 21.29
- 52 Week Low
- ICCH $14.78
- LNSR $2.67
- 52 Week High
- ICCH $23.96
- LNSR $9.23
- Technical
- Relative Strength Index (RSI)
- ICCH 48.99
- LNSR 51.28
- Support Level
- ICCH $23.23
- LNSR $8.08
- Resistance Level
- ICCH $23.47
- LNSR $8.72
- Average True Range (ATR)
- ICCH 0.05
- LNSR 0.59
- MACD
- ICCH -0.02
- LNSR -0.08
- Stochastic Oscillator
- ICCH 25.00
- LNSR 48.68
About ICCH ICC Holdings Inc.
ICC Holdings Inc is a specialty insurance carrier underwriting commercial multi-peril, liquor liability, worker's compensation, and umbrella liability coverages for the food and beverage industry. The company markets its products through a network of independent agents in Colorado, Illinois, Indiana, Iowa, Kansas, Minnesota, Missouri, Pennsylvania, Ohio, and Wisconsin.
About LNSR LENSAR Inc.
LENSAR Inc is a commercial-stage medical device company focused on designing, developing and marketing a femtosecond laser system for the treatment of cataracts. The company Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency and reproducibility by providing imaging, simplified procedure planning, efficient design and precision. Its product portfolio consists of the LENSAR Laser System with Streamline IV and IntelliAxis and its associated consumable components. The consumable portion of the system consists of a disposable patient interface device, or PID, kit and a procedure license. Each procedure on each system requires the use of a PID kit.